🔎 Trials Near Me

Home › Rectal Cancer › Missouri › Kansas City

Rectal Cancer clinical trials in Kansas City, MO

5 studies for Rectal Cancer are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

RecruitingHealthy volunteers welcome
  • University Health Truman Medical Center, Kansas City
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • and 1 more
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

RecruitingPhase 3
  • Saint Luke's Cancer Institute ( Site 0082), Kansas City
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997497

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting
  • Kansas City Veterans Affairs Medical Center, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673

Integrated Cancer Repository for Cancer Research

RecruitingObservational studyHealthy volunteers welcome
  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • and 1 more
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Kansas City
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Rectal Cancer trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.